Alcon Debuts as Independent, Publicly Traded Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500, Nasdaq futures edge up as chip stocks gain; US-Iran tensions in focus
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil rises as US-Iran conflict clouds peace prospects
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
Alcon (ALC) to Debut on NYSE Following Novartis Spin-Off
April 9, 2019 6:17 AM EDTAlcon (NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced its debut as an independent, publicly traded company and the completion of its separation from Novartis (NYSE: NVS). The companys shares begin trading today on the SIX Swiss Exchange and New York Stock Exchange (NYSE) under the symbol ALC.
Alcon is the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care. The company has a global presence in 74 countries and serves patients in more than 140,... More
